Open AccessDurable complete response with a short course of streptozotocin plus doxorubicin combination in malignant metastatic insulinoma
Author(s) -
Fatih Karataş,
Süleyman Şahin,
Aydın Aytekin,
Muhammet Bekir Hacıoğlu,
Gökşen İnanç Imamoğlu,
Mustafa Altınbaş
Publication year - 2018
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.188293
Subject(s) - capecitabine , insulinoma , streptozotocin , medicine , temozolomide , doxorubicin , oncology , combination therapy , chemotherapy , combination chemotherapy , cancer , diabetes mellitus , insulin , endocrinology , colorectal cancer
Due to the cytotoxic effects of old chemotherapy regimens used in the islet cell tumors, capecitabine plus temozolomide combination has now become the first choice in the treatment of malignant insulinoma (MIoma). We present this case to emphasize and remind that a durable complete response in advanced stage MIoma may be achieved with a short course of streptozotocin plus doxorubicin combination.